Vin Singh predicts that after Bullfrog AI signs its first major pharmaceutical deal, subsequent sales cycles will shorten from over 12 months to 6 months or less.

Vin Singh expects Bullfrog AI to close multiple deals with large pharmaceutical companies during 2026.

Bullfrog AI shifted its focus from smaller biotech companies to large pharmaceutical companies because the biotechs often lacked the budget and understanding of AI's value.